Announcements Trials
Browse Landscape

Phase

Phase NA 2Phase 2 1

Status

Completed 44Unknown 33Recruiting 19Terminated 14Active not recruiting 12Not yet recruiting 8Withdrawn 3No longer available 1

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Plasma cell 1Gynecologic 1

Conditions

Uterine Cervical Neoplasms 1Multiple Myeloma 1Histologically-confirmed Malignancies 1

Interventions

Radiotherapy 91pembrolizumab 88Cyclophosphamide 84Gemcitabine 70Cisplatin 70Magnetic Resonance Spectroscopy 65Carboplatin 60Radiosurgery 55Paclitaxel 55Nivolumab 48Dexamethasone 45Bevacizumab 42Biopsy 41Fluorouracil 39durvalumab 37Surveys and Questionnaires 36Docetaxel 36fludarabine 35Doxorubicin 35Radiation 33Oxaliplatin 33Capecitabine 33Rituximab 32fludarabine phosphate 31Leucovorin 31Cytarabine 30Melphalan 29Etoposide 28Pemetrexed 27Irinotecan 27

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Withdrawn × OTHER × Positron Emission Tomography Computed Tomography × Clear all
NCT04467281 2022-07-01

A Study of PET/CT Scans With the Radioactive Tracer 89Zr-DFO-Daratumumab in People With Myeloma

Memorial Sloan Kettering Cancer Center

Phase 2 Withdrawn
Plasma cell

Multiple Myeloma

NCT02139150 2019-09-17

Serial FLT PET Imaging in Cancer Patients for Monitoring of Response to Therapy

Memorial Sloan Kettering Cancer Center

Phase NA Withdrawn

Histologically-confirmed Malignancies

NCT00451945 2008-06-18

New Indications for Ultrasound in the Staging of Cervical Cancer

Rigshospitalet, Denmark

Phase NA Withdrawn
Gynecologic

Uterine Cervical Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡